The information on this website is intended to provide scientific information about Alkermes products and areas of therapeutic interest. Information may include data on investigational uses of approved or unapproved drugs for which safety and effectiveness have not been established. There is no guarantee that such uses will receive health authority approval and Alkermes does not recommend or suggest use of its medicines in a manner inconsistent with approved labeling.
This section includes selected Alkermes abstracts, posters or oral presentations, which have been accepted for congress presentations in the last 2 years. The content contained in this section is subject to congress copyright permissions.
Rakesh Bhattacharjee, MD1; Michael J. Thorpy, MD2; Sarah D. Meskill, MD3; Murad C. Assaad, MD4; Anne Marie Morse, DO5; Jennifer Gudeman, PharmD6,a; Brian Abaluck, MD7
1University of California, San Diego, San Diego, CA, USA; 2Albert Einstein College of Medicine, New York, NY, USA; 3Tricoastal Narcolepsy and Sleep Disorder Center, Sugar Land, TX, USA; 4Laureate Medical Group, Atlanta, GA, USA; 5Geisinger Commonwealth School of Medicine, Geisinger Medical Center, Janet Weis Children’s Hospital, Danville, PA, USA; 6Avadel Pharmaceuticals, Chesterfield, MO, USA; 7Alkermes, Inc., Waltham, MA, USA*; aAt the time of the study
